Supplementary Figure 4 from Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC
Atsuto Mouri, Hirotsugu Kenmotsu, Hiroshi Kagamu, Koichi Azuma et autres
0 citations
Keita Mori
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
373Publications signalées
6686Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentLung Cancer Research StudiesColorectal Cancer Treatments and StudiesCancer Immunotherapy and Biomarkers
Publications récentes
Supplementary Figure 2 from Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC
Atsuto Mouri, Hirotsugu Kenmotsu, Hiroshi Kagamu, Koichi Azuma et autres
0 citations
Supplementary Figure 3 from Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC
Atsuto Mouri, Hirotsugu Kenmotsu, Hiroshi Kagamu, Koichi Azuma et autres
0 citations
Supplementary Figure 1 from Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC
Atsuto Mouri, Hirotsugu Kenmotsu, Hiroshi Kagamu, Koichi Azuma et autres
0 citations
Supplementary Figure 6 from Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC
Atsuto Mouri, Hirotsugu Kenmotsu, Hiroshi Kagamu, Koichi Azuma et autres
0 citations
Data from Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC
Atsuto Mouri, Hirotsugu Kenmotsu, Hiroshi Kagamu, Koichi Azuma et autres
0 citations
Supplementary Figure 5 from Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC
Atsuto Mouri, Hirotsugu Kenmotsu, Hiroshi Kagamu, Koichi Azuma et autres
0 citations
Supplementary Table 1 from Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC
Atsuto Mouri, Hirotsugu Kenmotsu, Hiroshi Kagamu, Koichi Azuma et autres
0 citations
Efficacy of Osimertinib in Patients With Postoperative Recurrent Non–Small‐Cell Lung Cancer Harboring Sensitizing EGFR Mutations
Yuko Iida, Hirotsugu Kenmotsu, Keita Mori, Meiko Morita et autres
0 citationsThoracic Cancer
Safety and Efficacy of Concomitant Administration of Nanoliposomal Irinotecan + 5‐Fluorouracil/ Levo ‐Leucovorin for Pancreatic Cancer
Akane Wakabayashi, Rei Tanaka, Yurie Fukumuro, Keita Mori et autres
0 citationsCancer Reports
Effect of Inhalation of Hydrogen Gas on Postoperative Recovery After Hepatectomy: A Randomized, Double-Blind, Placebo-Controlled Trial
Hisashi Kosaka, Khanh Van Nguyen, Kosuke Matsui, Hideyuki Matsushima et autres
0 citationsHydrogen
Effect of the Insulated‐Tip Knife on Procedure Time in Endoscopic Submucosal Dissection for Colorectal Neoplasms: A Single‐Center, Randomized Controlled Trial (NANO Study)
Sayo Ito, Kinichi Hotta, Kenichiro Imai, Yoshihiro Kishida et autres
1 citationJournal of Gastroenterology and Hepatology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.